1. Home
  2. VTAK vs AQB Comparison

VTAK vs AQB Comparison

Compare VTAK & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$2.05

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Logo AquaBounty Technologies Inc.

AQB

AquaBounty Technologies Inc.

HOLD

Current Price

$1.05

Market Cap

4.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
AQB
Founded
2002
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VTAK
AQB
Price
$2.05
$1.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.8K
51.3K
Earning Date
11-13-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$730,000.00
N/A
Revenue This Year
$822.86
N/A
Revenue Next Year
$168.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
82.96
N/A
52 Week Low
$1.49
$0.47
52 Week High
$15.68
$2.95

Technical Indicators

Market Signals
Indicator
VTAK
AQB
Relative Strength Index (RSI) 47.34 41.27
Support Level $1.50 $0.86
Resistance Level $2.19 $1.09
Average True Range (ATR) 0.18 0.08
MACD 0.03 0.02
Stochastic Oscillator 61.45 53.25

Price Performance

Historical Comparison
VTAK
AQB

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: